Food and Dietary Supplement Safety and Regulation Conference
April 3, 2024 Washington, DC In-Person & Virtual Event
Agenda
Agenda Subject to Change
All Times Listed in Eastern Time
Wednesday, April 3
FDLI Welcome
Christine M. Simmon, President & CEO, FDLI
Keynote Addresses and Joint Q&A
Kristi Muldoon Jacobs, Acting Director, Office of Food Additive Safety, CFSAN, FDA
Cara Welch, Director, Office of Dietary Supplement Programs, CFSAN, FDA
Moderated by Deepti Kulkarni, Partner, Covington LLP and Chair, 2024 Food and Dietary Supplement Safety and Regulation Conference Planning Committee
10:30–10:50 AM | Networking Break
Recently, FDA recalled cinnamon apple puree and applesauce products due to high lead levels, and is now investigating whether the lead was intentionally added. This panel will cover FDA’s Closer to Zero initiative, economic food fraud, Prop 65 litigation involving heavy metals, and industry best practices for supply chain management to prevent these types of contamination events.
Andrea Bruce, Hogan Lovells
Tim Lombardo, Senior Director, EAS Consulting Group
Tom Neltner, National Director, Unleaded Kids
Paul South, Director, Division of Plant Products and Beverages, CFSAN-FDA
Moderated by Sharon Mayl, DLA Piper (US)
12:00–1:00 PM | Networking Luncheon
FDA’s Food Traceability Final Rule introduces new recordkeeping obligations for individuals involved in the manufacturing, processing, packaging, or storing of certain foods listed on the Food Traceability List (FTL), going beyond the current regulations. This panel will provide an overview of compliance, recordkeeping, implementation, and challenges related to Section 204 of the Food Safety Modernization Act (FSMA) for industry.
Andrea Ferrenz, Food Law Counsel, Campbell Soup Company
Rebecca Goldberg, Senior Counsel, OCC-FDA
Dave Tonucci, Principal, Ramboll US
Moderated by Elizabeth Fawell, Partner, Hogan Lovells
There has been a significant uptick in DOJ, FTC, and FDA enforcement actions against dietary supplement companies for misbranding, adulteration, and other noncompliance. This panel will explore the agencies’ enforcement trends, existing legal and regulatory frameworks for dietary supplements, and regulatory challenges for increasingly popular ingredients such as adaptogens and nootropics.
Victor DeFrancis, Attorney, Division of Advertising Practices, FTC
Jensen Jose, Regulatory Counsel, CSPI
Lisa Navarro, Principal, Ramboll US
Jack Wenik, Member, Epstein Becker & Green, PC
Moderated by Laura A. Rich, Counsel, Venable LLP
3:10–3:30 PM | Break
Consumer class actions against food and dietary supplement companies remain prevalent. This panel will address recent litigation, including the implications from the Montera v. Premier Nutrition Corporation decision, and class action trends for alleged PFAS and heavy metal contamination, all in the context of current regulatory uncertainties.
Maia Kats, Managing Member and Founder, Just Food Law
Jae Kim, Partner, DLA Piper
Jessica Tierney, Of Counsel, Jones Day
Moderated by Christopher Van Gundy, Partner, Sheppard Mullin LLP
This session will delve into the latest trends and future outlooks for issues around food and dietary supplement safety, including the reorganization of both CFSAN and ORA, and potential conflicts with FDA authority from state attempts to regulate ingredients, additives, and alternative proteins.
Riette van Laack, Director, Hyman, Phelps & McNamara, PC
Eric Marshall, Principal, Leavitt Partners
Christopher Van Gundy, Partner, Sheppard Mullin LLP
5:30 PM | Closing Remarks and Adjournment
